The objective of the project is to boost safety assessment in the development of new drugs by legacy data sharing

GMV is developing advanced data-integration infrastructure under open standards

The objective of the project is to boost safety assessment in the development of new drugs by legacy data sharing.

It is identified as a “Key Innovator” on the strength of its developments in natural deformation and handling of medical images

GMV’s inhouse development uTile now makes it possible for information on cancer patients to be shared without jeopardizing their privacy during research into new drugs and treatment

Hospitals, research centers and the pharmaceutical industry can now strike the right balance between harnessing healthcare data and respecting patient privacy, without exposing patient data to any risk of disclosure or even moving it from the respective health center

Apex hails the firm as an innovating company on the strength of its radiosurgery planner Radiance™

The worldwide intraoperative radiation therapy market, growing at a rate of 7% from 2019 a 2024, will be worth 67.8 million dollars by the end of that period